Clinical Predictors of Response to Omalizumab for Treatment of Chronic Urticaria

Clinical Predictors of Response to Omalizumab for Treatment of Chronic Urticaria

Methods We conducted a retrospective chart review of 52 patients over age 18 who received omalizumab for severe chronic urticaria through the Northwestern University Allergy-Immunology clinic (approved by NU IRB, STU#:IRB00037899).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB244-AB244
Hauptverfasser: Clayton, Elisabeth, MD, Saltoun, Carol A., MD, FAAAAI
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods We conducted a retrospective chart review of 52 patients over age 18 who received omalizumab for severe chronic urticaria through the Northwestern University Allergy-Immunology clinic (approved by NU IRB, STU#:IRB00037899).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.785